Hyloris Pharmaceuticals SA: Hyloris reports results for the full year 2021
Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant expansion of commercial footprint of Maxigesic